NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

First off, Flaskworks only received one million or so cash with the rest in some sort of risk. Second, I think LL was speaking more to a Rivers sized company running the show rather than whatever Flaskworks can bring to the table.


"I have my doubts about how a technology acquired for only $4.5 million can have any sort of near term benefit, but the description of Flaskworks' technology is exactly what Dr. Liau is saying is necessary for scaling DCVAX-L. I hope Flaskworks' IP protection is rock solid; it could end up being the special sauce for DCVAX-L. "